0000899243-16-012542.txt : 20160202
0000899243-16-012542.hdr.sgml : 20160202
20160202163051
ACCESSION NUMBER: 0000899243-16-012542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160201
FILED AS OF DATE: 20160202
DATE AS OF CHANGE: 20160202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hooks Corwin Dale
CENTRAL INDEX KEY: 0001665347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 161381255
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 5500 FLATIRON PARKWAY
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-01
0
0001466301
Clovis Oncology, Inc.
CLVS
0001665347
Hooks Corwin Dale
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY
BOULDER
CO
80301
0
1
0
0
See Remarks
Stock option (right to buy)
20.90
2016-02-01
4
A
0
10000
0.00
A
2026-02-01
Common Stock
10000
10000
D
Stock option (right to buy)
20.90
2016-02-01
4
A
0
10000
0.00
A
2026-02-01
Common Stock
10000
10000
D
The option shall vest as to 25% of the shares on February 1, 2017, and the remainder shall vest in substantially equal installments over the 48 months immediately following such date.
The option shall vest as to 50% of the shares on February 1, 2017, and the remainder shall vest on February 1, 2018.
Senior Vice President and Chief Commercial Officer
/s/ Corwin Dale Hooks
2016-02-01